BriaCell Therapeutics Corp. (BCTX)
Score window: May. 30, 2025 to May. 29, 2026
| Date | Form | Sentiment | Urgency | Summary | Open |
|---|---|---|---|---|---|
| Jan. 8, 2026 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a correspondence to the SEC regarding its Registration Statement on Form S-1. The company has withdrawn its previous request for an accel… | Read Filing EDGAR |
| Jan. 8, 2026 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has requested to withdraw its previous request for an accelerated effective date for its Registration Statement on Form S-1. Instead, the company, thro… | Read Filing EDGAR |
| Jan. 6, 2026 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a request to the SEC to accelerate the effective date of their Registration Statement on Form S-1 to January 8, 2026. This request indica… | Read Filing EDGAR |
| Jan. 6, 2026 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has requested the acceleration of the effective date for its Registration Statement on Form S-1 to January 8, 2026. ThinkEquity LLC, acting as the plac… | Read Filing EDGAR |
| Jul. 15, 2025 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a correspondence to the SEC regarding its Registration Statement on Form S-1. The company has withdrawn its previous request for an accel… | Read Filing EDGAR |
| Jul. 15, 2025 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a correspondence to the SEC regarding its Registration Statement on Form S-1. The company, through its placement agent ThinkEquity LLC, h… | Read Filing EDGAR |
| Jul. 14, 2025 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has requested to withdraw its previous request for an accelerated effective date for its Registration Statement on Form S-1. Instead, the company is no… | Read Filing EDGAR |
| Jul. 14, 2025 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a correspondence to the SEC regarding its Registration Statement on Form S-1. The company has withdrawn its previous request for an accel… | Read Filing EDGAR |
| Jul. 11, 2025 | CORRESP | Neutral/Informational | Low | BriaCell Therapeutics Corp. has submitted a correspondence to the SEC regarding its Registration Statement on Form S-1. The company, through its placement agent ThinkEquity LLC, h… | Read Filing EDGAR |
| Jul. 11, 2025 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a correspondence to the SEC regarding their Registration Statement on Form S-1. The company has withdrawn its previous request for an acc… | Read Filing EDGAR |
| Jul. 8, 2025 | CORRESP | Neutral/Informational | Moderate | The correspondence from ThinkEquity LLC to the SEC pertains to BriaCell Therapeutics Corp.'s Registration Statement on Form S-1. ThinkEquity, acting as the placement agent, is req… | Read Filing EDGAR |
| Jul. 8, 2025 | CORRESP | Neutral/Informational | Moderate | BriaCell Therapeutics Corp. has submitted a request to the SEC for the acceleration of the effective date of their Registration Statement on Form S-1. They are seeking to have it … | Read Filing EDGAR |
| Jun. 24, 2025 | UPLOAD | Neutral/Informational | Low | The SEC has communicated to BriaCell Therapeutics Corp. that they do not intend to review the company's draft registration statement submitted on June 18, 2025. The SEC has reques… | Read Filing EDGAR |